MedPath

ZOMIG

These highlights do not include all the information needed to use ZOMIG NASAL SPRAY. See full prescribing information for ZOMIG (zolmitriptan) NASAL SPRAYINITIAL U.S. APPROVAL: 1997

Approved
Approval ID

f2073122-5138-41ba-b791-a9b088bb98b7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 13, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Zolmitriptan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-955
Application NumberNDA021450
Product Classification
M
Marketing Category
C73594
G
Generic Name
Zolmitriptan
Product Specifications
Route of AdministrationNASAL
Effective DateJune 8, 2010
FDA Product Classification

INGREDIENTS (5)

ZOLMITRIPTANActive
Quantity: 5 mg in 1 1
Code: 2FS66TH3YW
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT
CITRIC ACID ANHYDROUSInactive
Code: XF417D3PSL
Classification: IACT
NITROGENInactive
Code: N762921K75
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZOMIG - FDA Drug Approval Details